MTOR and melanoma: One of the pathways shown to be aberrantly activated in both human and canine melanoma is the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) signalling cascade [10, 11].